Pathology at Johns Hopkins
The Department of Pathology at Johns Hopkins is preeminent nationally and globally in the study and treatment of human disease and in professional training in all areas of pathology and laboratory science. Currently, there are over 1400 people in the department, which includes approximately 120 full-time faculty, 36 residents, 45 graduate students, over 100 fellows, and 1000 staff members.
Find Faculty & Staff:
Our Training Programs
Get a Second Opinion
Learn about Your Disease
Laboratory Services
Grand Rounds
Pathobiology Thesis Seminar
Identifying Novel Therapeutic Targets in Acute Myeloid Leukemia
Speaker: Breann Yanagisawa
Place: CRB II, Rm 111
Advisors: Dr. Rick Jones
Learn more about our Pathobiology Program »
Save the Date!
October 14-15, 201717th Annual Current Topics in Gastrointestinal & Liver Pathology
Chevy Chase Bank Conference Center, The Sheikh Zayed Tower
more details »
Pathology Blog
Other Department Blogs
What's New?
A New Therapeutic target and Potential Biomarkers Identified in Alzheimer's Disease
June 21, 2017
Significant progress has been made over the past two decades on the pathogenesis of individual neurodegenerative diseases, including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, different neurodegenerative syndromes have been mainly studied mechanistically in isolation. There has been a lack of concerted effort to ascertain whether and how these pathogenic processes may be linked to one another.
read more »
Business Insider Interview with Dr. Anne Le, MD, HDR
June 20, 2017
The article highlights the translational aspect of cancer metabolism into clinical trials as a novel therapy for cancer patients. Business Insider solicited Dr. Anne Le's scientific opinion of how it works and what these treatments look like so far.
read more »
New Grant Funding Opportunities Available
June 12, 2017
Career Development project grant applications are now available to support investigators involved in projects related to cervical cancer. Priority will be given to investigators focusing on translational research projects, as well as to projects related to the cervical cancer and the human papillomavirus.
read more »
